These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 23705702)

  • 1. Impact of different components of the Skyrme nucleon-nucleon effective interaction on the nuclear density distribution.
    Seif WM; Hashem AS
    Sci Rep; 2023 Oct; 13(1):17592. PubMed ID: 37845270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutron Measurements and the Weak Nucleon-Nucleon Interaction.
    Snow WM
    J Res Natl Inst Stand Technol; 2005; 110(3):189-94. PubMed ID: 27308120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiative Neutron β-Decay in Effective Field Theory.
    Gardner S; Bernard V; Meißner UG; Zhang C
    J Res Natl Inst Stand Technol; 2005; 110(4):411-4. PubMed ID: 27308159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nested soft-collinear subtractions in NNLO QCD computations.
    Caola F; Melnikov K; Röntsch R
    Eur Phys J C Part Fields; 2017; 77(4):248. PubMed ID: 28515668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the oscillations of the nucleon electromagnetic form factors.
    Yang QH; Guo D; Dai LY; Haidenbauer J; Kang XW; Meißner UG
    Sci Bull (Beijing); 2023 Nov; 68(22):2729-2733. PubMed ID: 37833190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Should Be Next in Order?
    Int Dent J (Phila); 1901 Jun; 22(6):426-429. PubMed ID: 37912902
    [No Abstract]   [Full Text] [Related]  

  • 7. NuHamil : A numerical code to generate nuclear two- and three-body matrix elements from chiral effective field theory.
    Miyagi T
    Eur Phys J A Hadron Nucl; 2023; 59(7):150. PubMed ID: 37431444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for prevalent Z = 6 magic number in neutron-rich carbon isotopes.
    Tran DT; Ong HJ; Hagen G; Morris TD; Aoi N; Suzuki T; Kanada-En'yo Y; Geng LS; Terashima S; Tanihata I; Nguyen TT; Ayyad Y; Chan PY; Fukuda M; Geissel H; Harakeh MN; Hashimoto T; Hoang TH; Ideguchi E; Inoue A; Jansen GR; Kanungo R; Kawabata T; Khiem LH; Lin WP; Matsuta K; Mihara M; Momota S; Nagae D; Nguyen ND; Nishimura D; Otsuka T; Ozawa A; Ren PP; Sakaguchi H; Scheidenberger C; Tanaka J; Takechi M; Wada R; Yamamoto T
    Nat Commun; 2018 Apr; 9(1):1594. PubMed ID: 29686394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutron matter at next-to-next-to-next-to-leading order in chiral effective field theory.
    Tews I; Krüger T; Hebeler K; Schwenk A
    Phys Rev Lett; 2013 Jan; 110(3):032504. PubMed ID: 23373917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-mass nuclei from chiral nucleon-nucleon interactions.
    Hagen G; Papenbrock T; Dean DJ; Hjorth-Jensen M
    Phys Rev Lett; 2008 Aug; 101(9):092502. PubMed ID: 18851605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum Monte Carlo calculations with chiral effective field theory interactions.
    Gezerlis A; Tews I; Epelbaum E; Gandolfi S; Hebeler K; Nogga A; Schwenk A
    Phys Rev Lett; 2013 Jul; 111(3):032501. PubMed ID: 23909312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleon-nucleon correlations inside atomic nuclei: synergies, observations and theoretical models.
    Dalal R; Douglas MacGregor IJ
    Rep Prog Phys; 2024 Feb; 87(3):. PubMed ID: 38335543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromagnetic properties of nuclei from first principles: a case for synergies between experiment and theory.
    Roth R; Petri M
    Philos Trans A Math Phys Eng Sci; 2024 Jul; 382(2275):20230119. PubMed ID: 38910404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized chiral nucleon-nucleon interaction at next-to-next-to-leading order.
    Ekström A; Baardsen G; Forssén C; Hagen G; Hjorth-Jensen M; Jansen GR; Machleidt R; Nazarewicz W; Papenbrock T; Sarich J; Wild SM
    Phys Rev Lett; 2013 May; 110(19):192502. PubMed ID: 23705702
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.